Tierra Biosciences Secures $11.4M in Series A Funding to Revolutionize Protein Discovery with AI-Guided Technology
Tierra Biosciences is pioneering in providing predictive AI-guided cell-free technology.
![Tierra Biosciences Secures $11.4M in Series A Funding to Revolutionize Protein Discovery with AI-Guided Technology](/content/images/size/w1200/2024/03/Tierra-Biosciences.jpg)
Company Name: Tierra Biosciences
Location: San Leandro, CA
Sector: AI-Guided Cell-Free Technology
Funding Details: Raised $11.4M in Series A funding, led by Material Impact, with participation from Prosus Ventures, In-Q-Tel (IQT), Hillspire, Freeflow Ventures, Creative Ventures, and Social Capital.
Purpose of Investment: To expand operations and its research and development sector.
Leadership: CEO Michael Nemzek
Product: Tierra Biosciences leverages a high-throughput cell-free platform and AI language models to offer engineered proteins. The technology facilitates rapid access to a wide range of proteins, supporting sectors like human health, environmental sustainability, and global food security.
About Company: Tierra Biosciences is pioneering in providing predictive AI-guided cell-free technology. The company is on a mission to democratize access to proteins, enhancing the discovery process across various critical sectors with its innovative platform.